Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published September 25, 2020 | Submitted
Report Open

The structure of the UDP-Glc/GlcNAc 4-epimerase from the human pathogen Campylobacter jejuni

Abstract

Worldwide, the food-born pathogen Campylobacter jejuni is the leading bacterial source of human gastroenteritis. C. jejuni produces a variety of diverse cell-surface carbohydrates that are essential for pathogenicity. A critical component of these oligo- and polysaccharides is the sugar N-acetylgalactosamine (GalNAc). The sole source of this sugar is the epimerization of UDP-N-acetylglucosamine (GlcNAc), a reaction catalyzed by the enzyme UDP-GlcNAc 4-epimerase (Gne). This enzyme is unique among known bacterial epimerases in that it also catalyzes the equivalent reaction with the non-N-acetylated sugars. Understanding how CjGne catalyzes these various interconversions is critical to designing novel inhibitors of this enzyme. Here, to further the mechanistic understanding we present a 2.0Å structure of CjGne with its NAD⁺ co-factor bound. Based on novel features found in the structure we perform a variety of biochemical studies to probe the mechanism and compare these results to another bifunctional epimerase, human GalE. We further show that ebselen, previously identified for inhibition of HsGalE, is active against CjGne, suggesting a route for antibiotic development.

Additional Information

The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license. This version posted September 22, 2020. We thank Hazel Holden (Wisconsin) for expression plasmids for HsGalE. We are grateful to Nathan Dalleska (Caltech) for assistance with the capillary electrophoresis at the Environmental Analysis Center and Jens Kaiser and Pavle Nikolovski (Caltech) for crystallography help through the Molecular Observatory. This work was supported by grants from the National Institutes of Health (NIH) National Institute of General Medicine (NIGMS) awards GM105385 and GM114611 (to WMC). This research was undertaken in part using the 12-2 beamline at the Stanford Synchrotron Radiation Lightsource (SSRL). Operations at SSRL are supported by the US Department of Energy and the National Institutes of Health (NIH). The authors declare no conflicts of interest in regards to this manuscript.

Attached Files

Submitted - 2020.09.22.308395v1.full.pdf

Files

2020.09.22.308395v1.full.pdf
Files (5.9 MB)
Name Size Download all
md5:9b8b848931769da4e7cba167baefaf1d
5.9 MB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 20, 2023